🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
Last 3 Months
›
Biotechnology Industry
Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(3515)
All (3515)
Buys (310)
Sells (3205)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
PALVELLA THERAPEUTICS, INC.
(PVLA)
Goin Kathleen
— Chief Operating Officer
Feb 18, 2026
Sale
Shares
1,276
Price
$79.97
Total Value
$102.04K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PALVELLA THERAPEUTICS, INC.
(PVLA)
Goin Kathleen
— Chief Operating Officer
Feb 18, 2026
Sale
Shares
3,026
Price
$79.16
Total Value
$239.53K
Shares Held After
1,276
% of Holdings
70.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Voyager Therapeutics, Inc.
(VYGR)
Carter Todd Alfred
— Chief Scientific Officer
Feb 18, 2026
Sale
Shares
3,301
Price
$3.44
Total Value
$11.36K
Shares Held After
149,892
% of Holdings
2.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Keros Therapeutics, Inc.
(KROS)
Cho Esther
— SVP, General Counsel
Feb 18, 2026
Sale
Shares
4,745
Price
$16.35
Total Value
$77.58K
Shares Held After
39,755
% of Holdings
10.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Voyager Therapeutics, Inc.
(VYGR)
Sandrock Alfred
— Director
Feb 18, 2026
Sale
Shares
11,732
Price
$3.41
Total Value
$40.01K
Shares Held After
498,257
% of Holdings
2.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
RECURSION PHARMACEUTICALS, INC.
(RXRX)
Taylor Ben R
— Chief Financial Officer
Feb 18, 2026
Sale
Shares
13,426
Price
$3.08
Total Value
$41.35K
Shares Held After
1,195,349
% of Holdings
1.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
KalVista Pharmaceuticals, Inc.
(KALV)
Yea Christopher
— CHIEF DEVELOPMENT OFFICER
Feb 18, 2026
Sale
Shares
1,109
Price
$15.00
Total Value
$16.64K
Shares Held After
224,173
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
KalVista Pharmaceuticals, Inc.
(KALV)
Audhya Paul K.
— CHIEF MEDICAL OFFICER
Feb 18, 2026
Sale
Shares
1,163
Price
$15.00
Total Value
$17.45K
Shares Held After
133,087
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
KalVista Pharmaceuticals, Inc.
(KALV)
Palleiko Benjamin L
— Director
Feb 18, 2026
Sale
Shares
1,038
Price
$15.00
Total Value
$15.57K
Shares Held After
429,667
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Rapport Therapeutics, Inc.
(RAPP)
Ceesay Abraham
— Director
Feb 18, 2026
Sale
Shares
2,100
Price
$29.80
Total Value
$62.57K
Shares Held After
20,729
% of Holdings
9.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Rapport Therapeutics, Inc.
(RAPP)
Ceesay Abraham
— Director
Feb 18, 2026
Sale
Shares
2,983
Price
$29.04
Total Value
$86.64K
Shares Held After
22,829
% of Holdings
11.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Rapport Therapeutics, Inc.
(RAPP)
Ceesay Abraham
— Director
Feb 18, 2026
Sale
Shares
2,281
Price
$29.80
Total Value
$67.97K
Shares Held After
556,247
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Rapport Therapeutics, Inc.
(RAPP)
Ceesay Abraham
— Director
Feb 18, 2026
Sale
Shares
3,552
Price
$29.05
Total Value
$103.19K
Shares Held After
558,528
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
EXELIXIS, INC.
(EXEL)
Smith Julie
— Director
Feb 18, 2026
Sale
Shares
20,030
Price
$44.30
Total Value
$887.33K
Shares Held After
20,590
% of Holdings
49.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
EXELIXIS, INC.
(EXEL)
Smith Julie
— Director
Feb 18, 2026
Sale
Shares
44,087
Price
$44.50
Total Value
$1.96M
Shares Held After
20,590
% of Holdings
68.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GERON CORP
(GERN)
ROBERTSON MICHELLE
— EVP, CHIEF FINANCIAL OFFICER
Feb 18, 2026
Sale
Shares
9,855
Price
$1.94
Total Value
$19.12K
Shares Held After
17,645
% of Holdings
35.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PTC THERAPEUTICS, INC.
(PTCT)
Boulding Mark Elliott
— EXEC. VP AND CLO
Feb 18, 2026
Sale
Shares
3,081
Price
$69.36
Total Value
$213.70K
Shares Held After
108,231
% of Holdings
2.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Gemini Therapeutics, Inc.
(GMTX)
Franchi Jean M.
— Chief Financial Officer
Feb 18, 2026
Sale
Shares
3,684
Price
$65.89
Total Value
$242.73K
Shares Held After
71,343
% of Holdings
4.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Gemini Therapeutics, Inc.
(GMTX)
Franchi Jean M.
— Chief Financial Officer
Feb 18, 2026
Sale
Shares
3,397
Price
$65.01
Total Value
$220.84K
Shares Held After
75,027
% of Holdings
4.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Immunocore Holdings plc
(IMCR)
Berman David M
— HEAD OF R&D
Feb 18, 2026
Sale
Shares
5,965
Price
$32.35
Total Value
$192.97K
Shares Held After
5,859
% of Holdings
50.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Immunocore Holdings plc
(IMCR)
St Leger Tina Amber
— CHIEF HR OFFICER
Feb 18, 2026
Sale
Shares
1,000
Price
$32.35
Total Value
$32.35K
Shares Held After
1,119
% of Holdings
47.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Immunocore Holdings plc
(IMCR)
GOLL JOHN
— SVP, FINANCE & CAO
Feb 18, 2026
Sale
Shares
698
Price
$32.35
Total Value
$22.58K
Shares Held After
653
% of Holdings
51.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Immunocore Holdings plc
(IMCR)
Jallal Bahija
— Director
Feb 18, 2026
Sale
Shares
11,474
Price
$32.35
Total Value
$371.18K
Shares Held After
12,343
% of Holdings
48.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
VERTEX PHARMACEUTICALS INC / MA
(VRTX)
Tatsis Ourania
— EVP, Chief Reg. & Quality Off.
Feb 18, 2026
Sale
Shares
368
Price
$473.68
Total Value
$174.31K
Shares Held After
48,650
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Precision BioSciences, Inc.
(DTIL)
SMITH J. JEFFERSON
— Chief Research Officer
Feb 18, 2026
Sale
Shares
4,925
Price
$3.84
Total Value
$18.91K
Shares Held After
121,926
% of Holdings
3.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Precision BioSciences, Inc.
(DTIL)
Amoroso Michael
— Director
Feb 18, 2026
Sale
Shares
20,559
Price
$3.84
Total Value
$78.95K
Shares Held After
243,392
% of Holdings
7.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Precision BioSciences, Inc.
(DTIL)
Scimeca Dario
— General Counsel and Secretary
Feb 18, 2026
Sale
Shares
4,925
Price
$3.84
Total Value
$18.91K
Shares Held After
56,457
% of Holdings
8.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Precision BioSciences, Inc.
(DTIL)
Kelly John Alexander
— Chief Financial Officer
Feb 18, 2026
Sale
Shares
8,149
Price
$3.84
Total Value
$31.29K
Shares Held After
125,883
% of Holdings
6.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
VERTEX PHARMACEUTICALS INC / MA
(VRTX)
Ambrose Kristen
— SVP & Chief Accounting Officer
Feb 18, 2026
Sale
Shares
638
Price
$473.68
Total Value
$302.21K
Shares Held After
7,750
% of Holdings
7.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Seer, Inc.
(SEER)
Farokhzad Omid
— Director
Feb 18, 2026
Sale
Shares
24,385
Price
$1.99
Total Value
$48.65K
Shares Held After
3,349,064
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
VERTEX PHARMACEUTICALS INC / MA
(VRTX)
Atkinson Edward Morrow III
— EVP, Chief Technical Ops. Off.
Feb 18, 2026
Sale
Shares
817
Price
$473.68
Total Value
$387.00K
Shares Held After
20,727
% of Holdings
3.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
VERTEX PHARMACEUTICALS INC / MA
(VRTX)
Biller Jonathan
— EVP and Chief Legal Officer
Feb 18, 2026
Sale
Shares
1,244
Price
$473.68
Total Value
$589.26K
Shares Held After
15,748
% of Holdings
7.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Seer, Inc.
(SEER)
Horn David R.
— PRESIDENT & CFO
Feb 18, 2026
Sale
Shares
7,743
Price
$1.99
Total Value
$15.45K
Shares Held After
501,262
% of Holdings
1.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
VERTEX PHARMACEUTICALS INC / MA
(VRTX)
Bunnage Mark E.
— EVP, Chief Scientific Officer
Feb 18, 2026
Sale
Shares
1,182
Price
$473.68
Total Value
$559.89K
Shares Held After
8,486
% of Holdings
12.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Solid Biosciences Inc.
(SLDB)
Cumbo Alexander
— Director
Feb 18, 2026
Sale
Shares
16,644
Price
$5.82
Total Value
$96.92K
Shares Held After
235,405
% of Holdings
6.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Solid Biosciences Inc.
(SLDB)
Brooks Gabriel
— Chief Medical Officer
Feb 18, 2026
Sale
Shares
0
Price
$5.82
Total Value
$0.00
Shares Held After
89,466
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Solid Biosciences Inc.
(SLDB)
Tan Kevin
— CFO & Treasurer
Feb 18, 2026
Sale
Shares
5,404
Price
$5.82
Total Value
$31.47K
Shares Held After
99,422
% of Holdings
5.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Solid Biosciences Inc.
(SLDB)
Howton David T
— Chief Operating Officer
Feb 18, 2026
Sale
Shares
7,469
Price
$5.82
Total Value
$43.49K
Shares Held After
105,077
% of Holdings
6.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Solid Biosciences Inc.
(SLDB)
Ganot Ilan
— Director
Feb 18, 2026
Sale
Shares
2,658
Price
$5.82
Total Value
$15.48K
Shares Held After
27,474
% of Holdings
8.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Solid Biosciences Inc.
(SLDB)
Herzich Paul
— Chief Technology Officer
Feb 18, 2026
Sale
Shares
3,616
Price
$5.82
Total Value
$21.06K
Shares Held After
72,638
% of Holdings
4.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Solid Biosciences Inc.
(SLDB)
Hanrahan Jessie
— Chief Regulatory Officer
Feb 18, 2026
Sale
Shares
4,134
Price
$5.82
Total Value
$24.07K
Shares Held After
74,318
% of Holdings
5.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Adagio Therapeutics, Inc.
(ADGI)
Andersen Jill
— Chief Legal Officer, Secretary
Feb 18, 2026
Sale
Shares
34,939
Price
$1.58
Total Value
$55.13K
Shares Held After
181,736
% of Holdings
16.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Adagio Therapeutics, Inc.
(ADGI)
Lee Timothy Edward
— Chief Commercial Officer
Feb 18, 2026
Sale
Shares
20,964
Price
$1.58
Total Value
$33.08K
Shares Held After
117,717
% of Holdings
15.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
EXELIXIS, INC.
(EXEL)
Hefti Brenda
— SVP and General Counsel
Feb 18, 2026
Sale
Shares
18,669
Price
$44.01
Total Value
$821.62K
Shares Held After
96,512
% of Holdings
16.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Adagio Therapeutics, Inc.
(ADGI)
Duke William E.
— Chief Financial Officer
Feb 18, 2026
Sale
Shares
20,964
Price
$1.58
Total Value
$33.08K
Shares Held After
107,717
% of Holdings
16.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Adagio Therapeutics, Inc.
(ADGI)
Green Julie
— Chief Human Resources Officer
Feb 18, 2026
Sale
Shares
20,964
Price
$1.58
Total Value
$33.08K
Shares Held After
107,717
% of Holdings
16.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Adagio Therapeutics, Inc.
(ADGI)
Allen Robert D. III
— Chief Scientific Officer
Feb 18, 2026
Sale
Shares
19,392
Price
$1.58
Total Value
$30.60K
Shares Held After
114,487
% of Holdings
14.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Avista Public Acquisition Corp. II
(AHPA)
Berkman Charles S
— Chief Legal Officer
Feb 18, 2026
Sale
Shares
9,673
Price
$1.71
Total Value
$16.54K
Shares Held After
392,700
% of Holdings
2.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Avista Public Acquisition Corp. II
(AHPA)
FOEHR MATTHEW W
— Director
Feb 18, 2026
Sale
Shares
30,843
Price
$1.71
Total Value
$52.74K
Shares Held After
4,403,277
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Avista Public Acquisition Corp. II
(AHPA)
GUSTAFSON KURT A
— Executive VP, Finance and CFO
Feb 18, 2026
Sale
Shares
9,301
Price
$1.71
Total Value
$15.90K
Shares Held After
268,851
% of Holdings
3.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 1651–1700 of 3515 transactions (page 34 of 71)
Version: v26.3.33